trending Market Intelligence /marketintelligence/en/news-insights/trending/o0cwvjvvt5evhqpukvgivg2 content esgSubNav
In This List

Canada's Maricann to buy Maltese cannabis company

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Canada's Maricann to buy Maltese cannabis company

Canada's Maricann Group Inc. signed a nonbinding letter of intent to acquire Malta's Medican Holdings Ltd. for US$10.1 million in cash and stock.

The transaction price will comprise US$7.6 million in common shares and US$2.5 million in cash, to be paid when the transaction closes.

A Medican unit is approved to receive a license in Malta. Maricann, which is transitioning its pharmaceutical business to Europe, said the license will allow it to import and make finished dose products and distribute medical cannabis in Malta and the EU.

The proposed acquisition is subject to completion of due diligence, obtaining applicable regulatory approvals and negotiation of the definitive agreements.